Position paper: The time for cooperative group study of ropeginterferon alfa-2b in young patients with myeloproliferative neoplasms is now

Affiliations

• ¹ Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
• ² PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA.
• ³ Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
• ⁴ The Leukemia & Lymphoma Society, Rye Brook, New York, USA.
• ⁵ Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.